Search research articles
Contact Us
Filters
Showing results (1201-1210 of 1,392) with videos related to
Page
of 140
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2016
Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer
Geoffrey Liu, Dongsheng Tu, Marcia Lewis, et al.
Blood Advances
|
November 24, 2020
The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor development
B M Reipert, B Gangadharan, C J Hofbauer, et al.
Blood
|
November 24, 2011
Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients
Amy D Shapiro, Margaret V Ragni, Leonard A Valentino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2013
Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: the NCIC Clinical Trials Group and AGITG CO.20 Trial
Lillian L Siu, Jeremy D Shapiro, Derek J Jonker, et al.
JACC. Heart Failure
|
May 16, 2024
Association of High-Density Lipoprotein Parameters and Risk of Heart Failure: A Multicohort Analysis
Ambarish Pandey, Kershaw V Patel, Matthew W Segar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2013
PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17
Christos S Karapetis, Derek Jonker, Manijeh Daneshmand, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 6, 2005
Aminopiperidine indazoles as orally efficacious melanin concentrating hormone receptor-1 antagonists
Anil Vasudevan, Andrew J Souers, Jennifer C Freeman, et al.
Nature Medicine
|
September 30, 1999
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
S Heymans, A Luttun, D Nuyens, et al.
The Journal of Urology
|
August 5, 2025
Risk Factors for First-Year Recurrence in Patients With Synchronous Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy and Complete Metastasectomy
Ali Ghasemzadeh, E Jason Abel, Jose A Karam, et al.
Urology
|
December 13, 2025
Outcomes of Patients With Localized Renal Cell Carcinoma on Immunosuppression Following Solid Organ Transplantation
Parth V Shah, Edwin Jason Abel, Joshua D Mezrich, et al.
Page
of 140
Search research articles
Search
Showing results (1201-1210 of 1,392) with videos related to
Sort By:
Page
of 140
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2016
Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer
Geoffrey Liu, Dongsheng Tu, Marcia Lewis, et al.
Blood Advances
|
November 24, 2020
The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor development
B M Reipert, B Gangadharan, C J Hofbauer, et al.
Blood
|
November 24, 2011
Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients
Amy D Shapiro, Margaret V Ragni, Leonard A Valentino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2013
Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: the NCIC Clinical Trials Group and AGITG CO.20 Trial
Lillian L Siu, Jeremy D Shapiro, Derek J Jonker, et al.
JACC. Heart Failure
|
May 16, 2024
Association of High-Density Lipoprotein Parameters and Risk of Heart Failure: A Multicohort Analysis
Ambarish Pandey, Kershaw V Patel, Matthew W Segar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2013
PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17
Christos S Karapetis, Derek Jonker, Manijeh Daneshmand, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 6, 2005
Aminopiperidine indazoles as orally efficacious melanin concentrating hormone receptor-1 antagonists
Anil Vasudevan, Andrew J Souers, Jennifer C Freeman, et al.
Nature Medicine
|
September 30, 1999
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
S Heymans, A Luttun, D Nuyens, et al.
The Journal of Urology
|
August 5, 2025
Risk Factors for First-Year Recurrence in Patients With Synchronous Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy and Complete Metastasectomy
Ali Ghasemzadeh, E Jason Abel, Jose A Karam, et al.
Urology
|
December 13, 2025
Outcomes of Patients With Localized Renal Cell Carcinoma on Immunosuppression Following Solid Organ Transplantation
Parth V Shah, Edwin Jason Abel, Joshua D Mezrich, et al.
Page
of 140